Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

Completed

Phase 3 Results

Summary of Purpose

The primary objective of this trial is to demonstrate the efficacy and safety of dabigatran etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 November 2014.

1 Nov 2005 6 Dec 2005 1 Apr 2009 Unavailable 1 Apr 2014 18 Nov 2010
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available